STOCK TITAN

[8-K] Clene Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Clene Inc. (CLNN) furnished an updated corporate presentation that includes preliminary unaudited figures for its cash and cash equivalents as of September 30, 2025, and the gross proceeds raised under its at-the-market equity distribution agreement from after September 30, 2025 through October 14, 2025. The presentation is attached as Exhibit 99.1.

The company notes these figures were prepared by management and remain subject to completion of financial closing procedures and potential audit adjustments. The materials are furnished under Items 2.02 and 7.01 and are not deemed “filed” for purposes of Section 18 of the Exchange Act, which means they are not subject to its liability provisions or automatically incorporated by reference into other filings.

Clene Inc. (CLNN) ha fornito una presentazione aziendale aggiornata che include dati preliminari non revisionati per la liquidità e equivalenti di liquidità al 30 settembre 2025, e i proventi lordi raccolti ai sensi del suo accordo di distribuzione azionaria all ATM dal 30 settembre 2025 al 14 ottobre 2025. La presentazione è allegata come Exhibit 99.1.

La società nota che queste cifre sono state prepare dal management e restano soggette al completamento delle procedure di chiusura contabile e a eventuali aggiustamenti di audit. I materiali sono forniti ai sensi degli Items 2.02 e 7.01 e non sono considerati “presentati” ai fini della Sezione 18 della Exchange Act, il che significa che non sono soggetti alle relative disposizioni di responsabilità o incorporati automaticamente per riferimento in altri filing.

Clene Inc. (CLNN) presentó una presentación corporativa actualizada que incluye datos preliminares no auditados para su caja y equivalentes de caja a fecha del 30 de septiembre de 2025, y los ingresos brutos recaudados bajo su acuerdo de distribución de acciones en el mercado desde después del 30 de septiembre de 2025 hasta el 14 de octubre de 2025. La presentación está adjunta como el Anexo 99.1.

La empresa señala que estas cifras fueron preparadas por la dirección y permanecen sujetas al cierre de procedimientos financieros y posibles ajustes de auditoría. Los materiales se proporcionan conforme a los Artículos 2.02 y 7.01 y no se consideran “presentados” a los efectos de la Sección 18 de la Ley de Intercambio, lo que significa que no están sujetos a sus disposiciones de responsabilidad ni incorporados automáticamente por referencia en otros archivos.

클리인 주식회사(CLNN)가 업데이트된 기업 프리젠테이션을 제공했으며, 예비 미감사 수치를 2025년 9월 30일 기준의 현금 및 현금성 자산과, 2025년 9월 30일 이후 2025년 10월 14일 사이에 자사 ATM(시장전분배) 계약에 따라 조달된 총수익을 포함합니다. 프리젠테이션은 Exhibit 99.1로 첨부되어 있습니다.

회사 측은 이 수치들이 경영진에 의해 작성되었고 재무 마감 절차의 완료 및 잠재적 감사 조정에 따라 달라질 수 있음을 밝힙니다. 이 자료는 Items 2.02 및 7.01에 따라 제공되며, 증권거래법 제18조의 목적상 “제출된” 것으로 간주되지 않으며, 따라서 그 책임 조항에 준거되거나 다른 제출물에 자동으로 참조로 포함되지 않습니다.

Clene Inc. (CLNN) a fourni une présentation d’entreprise mise à jour qui comprend des chiffres préliminaires non audités pour sa trésorerie et équivalents et pour les produits bruts levés dans le cadre de son accord de distribution d’actions sur le marché au fil de l’eau (ATM) du 30 septembre 2025 au 14 octobre 2025. La présentation est jointe en tant qu’Exhibit 99.1.

La société précise que ces chiffres ont été préparés par la direction et restent soumis à la finalisation des procédures de clôture financière et à d’éventuelles révisions d’audit. Les documents sont fournis en vertu des Articles 2.02 et 7.01 et ne sont pas considérés comme « déposés » au sens de la Section 18 du Exchange Act, ce qui signifie qu’ils ne sont pas soumis à ses dispositions de responsabilité ni automatiquement incorporés par référence dans d’autres dépôts.

Clene Inc. (CLNN) hat eine aktualisierte Unternehmenspräsentation vorgelegt, die vorläufige unaudited Zahlen für seine Barbestände und Barmitteläquivalente zum Stand vom 30. September 2025 sowie die Bruttoerlöse aus seiner am Markt verfügbaren Aktienverteilungsvereinbarung vom nach dem 30. September 2025 bis zum 14. Oktober 2025 enthält. Die Präsentation ist als Exhibit 99.1 beigefügt.

Das Unternehmen weist darauf hin, dass diese Zahlen von der Geschäftsführung erstellt wurden und der Abschluss der Finanzabschlüsse sowie mögliche Audit-Anpassungen noch erfolgen müssen. Die Unterlagen werden gemäß Items 2.02 und 7.01 bereitgestellt und gelten nicht als „eingereicht“ im Sinne von Section 18 des Exchange Act, was bedeutet, dass sie nicht den Haftungsvorschriften unterliegen oder automatisch durch Verweis in andere Einreichungen einbezogen werden.

قدمت شركة Clene Inc. (CLNN) عرضاً تقديمياً مؤسسياً محدثاً يتضمن أرقاماً ابتدائية غير مدققة لسيولتها النقدية وما يعادلها حتى 30 سبتمبر 2025، وإجمالي العوائد التي تم جمعها بموجب اتفاقية توزيع أسهم السوق المفتوح من ما بعد 30 سبتمبر 2025 حتى 14 أكتوبر 2025. العرض مرفق كـ Exhibit 99.1.

تشير الشركة إلى أن هذه الأرقام أعدتها الإدارة وتظل خاضعة لاستكمال إجراءات الإغلاق المالي وتعديلات التدقيق المحتملة. تُقدَّم المواد بموجب البنود 2.02 و7.01 وهي غير مُعتَبَرَة “مُقدمة” لأغراض المادة 18 من قانون التبادل، مما يعني أنها ليست خاضعة لأحكام المسؤولية ولا مدمَجة تلقائياً بالاستشهاد في ملفات أخرى.

Clene Inc.(CLNN)已提供 更新的公司介绍,包含 初步未经审计 的现金及现金等价物数字,截止至 2025 年 9 月 30 日,以及自 2025 年 9 月 30 日之后至 2025 年 10 月 14 日之间,其“市场在售股票分配”协议项下募集的总额。该演示文稿作为 Exhibit 99.1 附件。

公司指出这些数字由管理层编制,仍需完成财务结算程序并可能进行审计调整。该材料是在第 2.02 条和第 7.01 条下提供的,且不被视为《交易法》第 18 条所“提交”的,意味着它们不受其责任条款的约束,也不会自动通过引用入其他申报文件中。

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Clene Inc. (CLNN) ha fornito una presentazione aziendale aggiornata che include dati preliminari non revisionati per la liquidità e equivalenti di liquidità al 30 settembre 2025, e i proventi lordi raccolti ai sensi del suo accordo di distribuzione azionaria all ATM dal 30 settembre 2025 al 14 ottobre 2025. La presentazione è allegata come Exhibit 99.1.

La società nota che queste cifre sono state prepare dal management e restano soggette al completamento delle procedure di chiusura contabile e a eventuali aggiustamenti di audit. I materiali sono forniti ai sensi degli Items 2.02 e 7.01 e non sono considerati “presentati” ai fini della Sezione 18 della Exchange Act, il che significa che non sono soggetti alle relative disposizioni di responsabilità o incorporati automaticamente per riferimento in altri filing.

Clene Inc. (CLNN) presentó una presentación corporativa actualizada que incluye datos preliminares no auditados para su caja y equivalentes de caja a fecha del 30 de septiembre de 2025, y los ingresos brutos recaudados bajo su acuerdo de distribución de acciones en el mercado desde después del 30 de septiembre de 2025 hasta el 14 de octubre de 2025. La presentación está adjunta como el Anexo 99.1.

La empresa señala que estas cifras fueron preparadas por la dirección y permanecen sujetas al cierre de procedimientos financieros y posibles ajustes de auditoría. Los materiales se proporcionan conforme a los Artículos 2.02 y 7.01 y no se consideran “presentados” a los efectos de la Sección 18 de la Ley de Intercambio, lo que significa que no están sujetos a sus disposiciones de responsabilidad ni incorporados automáticamente por referencia en otros archivos.

클리인 주식회사(CLNN)가 업데이트된 기업 프리젠테이션을 제공했으며, 예비 미감사 수치를 2025년 9월 30일 기준의 현금 및 현금성 자산과, 2025년 9월 30일 이후 2025년 10월 14일 사이에 자사 ATM(시장전분배) 계약에 따라 조달된 총수익을 포함합니다. 프리젠테이션은 Exhibit 99.1로 첨부되어 있습니다.

회사 측은 이 수치들이 경영진에 의해 작성되었고 재무 마감 절차의 완료 및 잠재적 감사 조정에 따라 달라질 수 있음을 밝힙니다. 이 자료는 Items 2.02 및 7.01에 따라 제공되며, 증권거래법 제18조의 목적상 “제출된” 것으로 간주되지 않으며, 따라서 그 책임 조항에 준거되거나 다른 제출물에 자동으로 참조로 포함되지 않습니다.

Clene Inc. (CLNN) a fourni une présentation d’entreprise mise à jour qui comprend des chiffres préliminaires non audités pour sa trésorerie et équivalents et pour les produits bruts levés dans le cadre de son accord de distribution d’actions sur le marché au fil de l’eau (ATM) du 30 septembre 2025 au 14 octobre 2025. La présentation est jointe en tant qu’Exhibit 99.1.

La société précise que ces chiffres ont été préparés par la direction et restent soumis à la finalisation des procédures de clôture financière et à d’éventuelles révisions d’audit. Les documents sont fournis en vertu des Articles 2.02 et 7.01 et ne sont pas considérés comme « déposés » au sens de la Section 18 du Exchange Act, ce qui signifie qu’ils ne sont pas soumis à ses dispositions de responsabilité ni automatiquement incorporés par référence dans d’autres dépôts.

Clene Inc. (CLNN) hat eine aktualisierte Unternehmenspräsentation vorgelegt, die vorläufige unaudited Zahlen für seine Barbestände und Barmitteläquivalente zum Stand vom 30. September 2025 sowie die Bruttoerlöse aus seiner am Markt verfügbaren Aktienverteilungsvereinbarung vom nach dem 30. September 2025 bis zum 14. Oktober 2025 enthält. Die Präsentation ist als Exhibit 99.1 beigefügt.

Das Unternehmen weist darauf hin, dass diese Zahlen von der Geschäftsführung erstellt wurden und der Abschluss der Finanzabschlüsse sowie mögliche Audit-Anpassungen noch erfolgen müssen. Die Unterlagen werden gemäß Items 2.02 und 7.01 bereitgestellt und gelten nicht als „eingereicht“ im Sinne von Section 18 des Exchange Act, was bedeutet, dass sie nicht den Haftungsvorschriften unterliegen oder automatisch durch Verweis in andere Einreichungen einbezogen werden.

false 0001822791 0001822791 2025-10-14 2025-10-14 0001822791 clnn:CommonStock00001ParValueCustomMember 2025-10-14 2025-10-14 0001822791 clnn:WarrantsToAcquireOnefortiethOfOneShareOfCommonStockFor23000PerShareCustomMember 2025-10-14 2025-10-14


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 14, 2025

CLENE INC.
(Exact name of registrant as specified in its charter)

 
Delaware
001-39834
85-2828339
(State or other jurisdiction
(Commission File Number)
(IRS Employer
of incorporation)
 
Identification No.)
     
6550 South Millrock Drive, Suite G50
Salt Lake City, Utah
 
84121
(Address of principal executive offices)
 
(Zip Code)
(801) 676-9695
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, $0.0001 par value
 
CLNN
 
The Nasdaq Capital Market
Warrants, to acquire one-fortieth of one share of Common Stock for $230.00 per share
  CLNNW  
The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

 
Item 2.02 Results of Operations and Financial Condition.
 
On October 14, 2025, Clene Inc. (“the Company”) released an updated corporate presentation (the “Corporate Presentation”) on its website, invest.clene.com, containing the Company’s preliminary unaudited (i) balance of cash and cash equivalents as of September 30, 2025 and (ii) gross proceeds raised from the Company’s equity distribution agreement (the “ATM Agreement”) subsequent to September 30, 2025 through October 14, 2025 (together, the “Financial Information”). The Corporate Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
 
The Financial Information is based on preliminary unaudited information available to the Company and has been prepared by and is the responsibility of management. The Company’s financial closing procedures for the three and nine months ended September 30, 2025 are not yet complete and, as a result, actual results may vary from the preliminary unaudited results presented herein due to the completion of the Company’s financial closing procedures audit procedures. The preliminary Financial Information has not been audited or reviewed by the Company’s independent registered public accounting firm and should not be viewed as a substitute for the Company’s full financial statements. It is possible that the Company or its independent registered public accounting firm may identify necessary adjustments to the preliminary unaudited Financial Information and those changes could be material. Accordingly, you should not place undue reliance on this preliminary unaudited data.
 
The information furnished in this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933 (the “Securities Act”), as amended, regardless of any general incorporation language in any such filings, except as shall be expressly set forth by specific reference in such a filing.
 
Item 7.01 Regulation FD Disclosure.
 
The information set forth in Item 2.02 of this Current Report on Form 8-K is incorporated into this Item 7.01 by reference.
 
The information furnished in this Item 7.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act regardless of any general incorporation language in any such filings, except as shall be expressly set forth by specific reference in such a filing.
 
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits
 
Exhibit Number   Exhibit Description
99.1   Corporate Presentation.
104   Cover Page Interactive Data File (formatted as Inline XBRL).
 
1

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
 
CLENE INC.
   
Date: October 14, 2025
By:
/s/ Robert Etherington
   
Robert Etherington
   
President and Chief Executive Officer
 
2
 

FAQ

What did Clene (CLNN) announce in this 8-K?

Clene furnished a corporate presentation with preliminary unaudited cash as of September 30, 2025 and ATM gross proceeds through October 14, 2025.

Where can I find the disclosed information for CLNN?

It is included in the Corporate Presentation furnished as Exhibit 99.1.

Is the financial information final and audited?

No. It is preliminary unaudited and subject to change upon completion of closing procedures and potential audit adjustments.

Are the materials considered 'filed' under the Exchange Act?

No. The information is furnished, not filed, and is not subject to Section 18 liabilities nor automatically incorporated by reference.

Which 8-K items apply to this CLNN disclosure?

The information is provided under Item 2.02 (Results of Operations and Financial Condition) and incorporated into Item 7.01 (Reg FD).

What period do the ATM proceeds cover for CLNN?

Gross proceeds under the ATM cover activity from after September 30, 2025 through October 14, 2025.
Clene

NASDAQ:CLNN

CLNN Rankings

CLNN Latest News

CLNN Latest SEC Filings

CLNN Stock Data

83.08M
6.96M
31.08%
16.55%
2.24%
Packaged Foods
Pharmaceutical Preparations
Link
United States
SALT LAKE CITY